The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-South Africa to ramp up COVID-19 vaccinations as opposition protests

Fri, 25th Jun 2021 14:08

(Updates with EFF march)

JOHANNESBURG, June 25 (Reuters) - Several thousand
supporters of a leftist party demonstrated outside the offices
of South Africa's health regulator on Friday to protest against
the slow coronavirus vaccine roll-out in Africa's worst-hit
country.

The protesters from the Economic Freedom Fighters (EFF) held
aloft placards and flags but few wore protective masks, a
Reuters photographer said.

Their march to the offices defied rules meant to curb a
third wave of infections. They demanded that Russian and Chinese
vaccines be authorised to speed up the vaccination process.

Officials said that South Africa - which has recorded more
than 1.8 million COVID-19 cases and more than 59,000 deaths -
aimed to double daily vaccinations in the next month.

Acting health minister Mmamoloko Kubayi-Ngubane said at a
news conference that it was irresponsible to hold marches and
other large gatherings while infections were surging.

South Africa's immunisation efforts were set back by the
revelation that AstraZeneca's vaccine is much less
effective against the dominant local coronavirus variant, and
the government subsequently found it hard to access supplies
from other manufacturers.

So far, only 2.5 million vaccinations have been administered
using either the one-shot Johnson & Johnson (J&J)
vaccine or the two-shot Pfizer alternative, out of a
population of 60 million people.

Nicholas Crisp, a senior health official, said more than
100,000 people had been vaccinated per day in the last two days
and the target for next week was 150,000 a day. The aim for
mid-July was 200,000, and 250,000 by the end of that month.

"The president has asked us to chase a target of 300,000 a
day," he said.

Kubayi-Ngubane said Pfizer had delivered nearly 4.5 million
vaccine doses in the second quarter and had committed to provide
just over 15.5 million doses in the third quarter.

J&J has delivered 500,000 shots for a research study
targeting healthcare workers, 300,000 last week and 1.2 million
on Thursday, Kubayi-Ngubane said.

A further 500,000 J&J doses are expected soon, but the
timing is not yet confirmed.

"With this flow of vaccines, we will be able to press ahead
with the vaccination of frontline workers sector by sector," she
said.

South Africa has started immunising health workers, those
aged over 60 years and education sector employees. From July 15
the over-50s will start getting the vaccine, she said.

(Reporting by Alexander Winning and Akhona Matshoba in
Johannesburg, and Siphiwe Sibeko in Pretoria, editing by Louise
Heavens and Angus MacSwan)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.